Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus
1 other identifier
observational
100
1 country
1
Brief Summary
- OCT, OCTA, fundus photography, and fundus autofluorescence ( FAF ) were used to observe the fundus physiological indexes of normal subjects and SLE patients, to explore the differences of subclinical retinal damage in SLE patients with different degrees of disease activity, to summarize the changes of subclinical retina in SLE patients without organic retinopathy, and to evaluate its correlation with disease activity, which is of great significance for improving the prognosis of visual function and improving the quality of life in SLE patients.
- By evaluating the visual psychophysical indicators, mainly the visual function test results of different colors and different frequencies, reflecting the functional status of the retina and the degree and characteristics of functional impairment in SLE patients with different degrees of disease activity, in order to screen out the clinical markers of SLE fundus lesions, and provide a reliable reference for the prevention and early intervention of visual impairment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedFirst Submitted
Initial submission to the registry
April 24, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
CompletedFirst Posted
Study publicly available on registry
July 1, 2026
CompletedJuly 1, 2026
April 1, 2026
12 months
April 24, 2026
June 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
contrast sensitivity
Day 1
Study Arms (2)
SLE
SLE patients without retinopathy
Control
Normal group
Eligibility Criteria
A total of 50 patients ( 100 eyes ) who met the inclusion criteria were collected from the patients diagnosed with SLE in the Department of Rheumatology and Immunology of the First Affiliated Hospital of Anhui Medical University. Among them, the diagnosis of SLE is based on the 2019 European Rheumatism Association ( EULAR ) / American Rheumatism Association ( ACR ) SLE diagnostic criteria. At the same time, 50 age-matched healthy adults ( 100 eyes ) were recruited as the normal control group.
You may qualify if:
- the best corrected visual acuity ( BCVA ) of all cases must be ≥ 1.0 according to the international standard visual acuity char;
- intraocular pressure ( IOP ) in the normal range, namely 10 mmHg ≤ IOP ≤ 21 mmHg ;
- visual field meter examination center and peripheral visual field without defect ;
- no degeneration of fundus retina ;
You may not qualify if:
- obvious abnormality in cranial MRI ;
- history of glaucoma, cataract, retinal vascular disease, retinitis pigmentosa and other eye diseases ;
- history of refractive surgery such as corneal refractive surgery and cataract surgery ;
- other major disease history or systemic lesions affecting the eye ;
- history of disease affecting cognitive function, can understand and cooperate with the examination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief physician, Doctoral supervisor
Study Record Dates
First Submitted
April 24, 2026
First Posted
July 1, 2026
Study Start
January 1, 2025
Primary Completion
December 31, 2025
Study Completion
June 30, 2026
Last Updated
July 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical and privacy considerations. Participants did not consent to data sharing in the informed consent form.